| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.
|
Heart Rhythm
|
2012
|
8.03
|
|
2
|
HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.
|
Heart Rhythm
|
2007
|
7.20
|
|
3
|
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
|
Europace
|
2012
|
5.84
|
|
4
|
An entirely subcutaneous implantable cardioverter-defibrillator.
|
N Engl J Med
|
2010
|
5.32
|
|
5
|
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.
|
Europace
|
2007
|
2.87
|
|
6
|
Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years.
|
J Am Coll Cardiol
|
2006
|
2.30
|
|
7
|
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
|
Heart Rhythm
|
2013
|
2.22
|
|
8
|
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy.
|
J Am Coll Cardiol
|
2009
|
2.21
|
|
9
|
Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation.
|
J Am Coll Cardiol
|
2002
|
2.15
|
|
10
|
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.
|
J Interv Card Electrophysiol
|
2012
|
2.08
|
|
11
|
Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition.
|
J Cardiovasc Electrophysiol
|
2008
|
1.63
|
|
12
|
Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables.
|
Europace
|
2009
|
1.45
|
|
13
|
Towards more effective techniques for catheter ablation of atrial fibrillation: to aim for electrical disconnection of pulmonary veins or not?
|
Eur Heart J
|
2005
|
1.42
|
|
14
|
Electroanatomic substrate of idiopathic left ventricular tachycardia: unidirectional block and macroreentry within the purkinje network.
|
Circulation
|
2002
|
1.25
|
|
15
|
Update of the guidelines on sudden cardiac death of the European Society of Cardiology.
|
Eur Heart J
|
2003
|
1.21
|
|
16
|
Venice Chart international consensus document on atrial fibrillation ablation: 2011 update.
|
J Cardiovasc Electrophysiol
|
2012
|
1.16
|
|
17
|
Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report.
|
J Am Coll Cardiol
|
2011
|
1.10
|
|
18
|
Venice Chart International Consensus document on ventricular tachycardia/ventricular fibrillation ablation.
|
J Cardiovasc Electrophysiol
|
2010
|
1.00
|
|
19
|
Percutaneous closure of multiple defects of the atrial septum: procedural results and long-term follow-up.
|
Catheter Cardiovasc Interv
|
2010
|
0.92
|
|
20
|
Illicit drugs and cardiac arrhythmias in athletes.
|
Eur J Cardiovasc Prev Rehabil
|
2007
|
0.86
|
|
21
|
Current state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillator.
|
J Interv Card Electrophysiol
|
2009
|
0.84
|
|
22
|
Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure.
|
J Interv Card Electrophysiol
|
2013
|
0.84
|
|
23
|
Rationale and design of VENTURE-AF: a randomized, open-label, active-controlled multicenter study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation.
|
J Interv Card Electrophysiol
|
2014
|
0.83
|
|
24
|
Arrhythmogenic effects of illicit drugs in athletes.
|
Ital Heart J
|
2003
|
0.81
|
|
25
|
Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial.
|
Europace
|
2005
|
0.81
|
|
26
|
Surgical treatment of arrhythmias in adults with congenital heart defects.
|
Int J Cardiol
|
2007
|
0.81
|
|
27
|
An unusual case of permanent junctional reciprocating tachycardia: Successful ablation at the mitral annulus-aorta junction.
|
J Interv Card Electrophysiol
|
2008
|
0.81
|
|
28
|
Microvolt T-wave alternans as predictor of electrophysiological testing results in professional competitive athletes.
|
Ann Noninvasive Electrocardiol
|
2004
|
0.81
|
|
29
|
Ablation of paroxysmal and persistent atrial fibrillation with multielectrode phased radiofrequency duty-cycled catheters: long-term results from a large cohort of patients.
|
J Cardiovasc Med (Hagerstown)
|
2013
|
0.81
|
|
30
|
Shock efficacy of the entirely subcutaneous defibrillator for termination of spontaneous ventricular fibrillation in Brugada syndrome.
|
Heart Rhythm
|
2013
|
0.80
|
|
31
|
A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia.
|
Eur Heart J
|
2017
|
0.79
|
|
32
|
Arrhythmia detection in single- and dual-chamber implantable cardioverter defibrillators: the more leads, the better?
|
J Cardiovasc Electrophysiol
|
2009
|
0.79
|
|
33
|
Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D Trial.
|
Pacing Clin Electrophysiol
|
2006
|
0.79
|
|
34
|
Prospective European survey on atrial fibrillation ablation: clinical characteristics of patients and ablation strategies used in different countries.
|
J Cardiovasc Electrophysiol
|
2014
|
0.78
|
|
35
|
Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation.
|
Am J Cardiol
|
2011
|
0.77
|
|
36
|
Fontan conversion with concomitant arrhythmia surgery for the failing atriopulmonary connections: mid-term results from a single centre.
|
Cardiol Young
|
2011
|
0.76
|
|
37
|
Silent cerebral embolism and new technologies for catheter ablation of atrial fibrillation: time to take a deep breath.
|
J Cardiovasc Electrophysiol
|
2012
|
0.75
|
|
38
|
Searching for left atrial thrombi prior to catheter ablation of atrial fibrillation: are there patients who can safely avoid preablation transesophageal echocardiography?
|
J Cardiovasc Electrophysiol
|
2008
|
0.75
|
|
39
|
Congenital complete atrioventricular block in the early pediatric population.
|
Heart Int
|
2006
|
0.75
|
|
40
|
Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented?
|
Eur Heart J
|
2009
|
0.75
|
|
41
|
The case of chronic bifascicular block: still a worrying ECG finding?
|
Europace
|
2009
|
0.75
|
|
42
|
Sudden unexpected cardiac death as the first symptom in young people: some useful clinical information from a systematic standardized anatomical study.
|
J Cardiovasc Med (Hagerstown)
|
2016
|
0.75
|
|
43
|
Role of psoriasis as independent predictor of cardiovascular disease: a meta-regression analysis.
|
Int J Cardiol
|
2013
|
0.75
|
|
44
|
[The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
|
G Ital Cardiol (Rome)
|
2011
|
0.75
|
|
45
|
[AIAC Guidelines on the management and treatment of atrial fibrillation. Update 2013. Associazione Italiana di Aritmologia e Cardiostimolazione].
|
G Ital Cardiol (Rome)
|
2013
|
0.75
|
|
46
|
Development of an entirely subcutaneous implantable cardioverter-defibrillator.
|
Prog Cardiovasc Dis
|
2012
|
0.75
|
|
47
|
[2010 AIAC Guidelines for the management and treatment of atrial fibrillation].
|
G Ital Cardiol (Rome)
|
2011
|
0.75
|
|
48
|
Left bundle branch block tachycardia in a case of dextrocardia: what is the mechanism?
|
J Cardiovasc Electrophysiol
|
2013
|
0.75
|
|
49
|
Atrial fibrillation: an old disease still being updated.
|
J Med Liban
|
2013
|
0.75
|
|
50
|
Don't get fooled: atrial and ventricular undersensing or atrial loss of capture?
|
Europace
|
2012
|
0.75
|
|
51
|
[Atrial fibrillation ablation in the real world].
|
G Ital Cardiol (Rome)
|
2010
|
0.75
|
|
52
|
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies.
|
EuroIntervention
|
2016
|
0.75
|
|
53
|
[Drugs and athletic activity: do they fit together?].
|
G Ital Cardiol (Rome)
|
2010
|
0.75
|
|
54
|
[Subcutaneous implantable cardioverter-defibrillators].
|
G Ital Cardiol (Rome)
|
2012
|
0.75
|
|
55
|
Compliance to MADIT and MUSTT criteria for implantable cardioverter defibrillator therapy in the pre-SCD-Heft and MADIT II era. Data from a multicenter Italian study.
|
Int J Cardiol
|
2009
|
0.75
|
|
56
|
Regression of warfarin-resistant left atrial appendage thrombus after ablation of atrial fibrillation and permanent pacing.
|
J Cardiovasc Med (Hagerstown)
|
2006
|
0.75
|
|
57
|
Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban.
|
Thromb Haemost
|
2016
|
0.75
|
|
58
|
Diagnostic capabilities of devices for cardiac resynchronization therapy.
|
J Cardiovasc Med (Hagerstown)
|
2010
|
0.75
|
|
59
|
Ventricular tachycardia as the first manifestation of disease: an element with different clinical settings.
|
J Cardiovasc Med (Hagerstown)
|
2017
|
0.75
|
|
60
|
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient.
|
Europace
|
2009
|
0.75
|
|
61
|
Recommendations of the European Cardiac Arrhythmia Society Committee on device failures and complications.
|
Pacing Clin Electrophysiol
|
2006
|
0.75
|
|
62
|
[The CONVERT trial].
|
G Ital Cardiol (Rome)
|
2009
|
0.75
|
|
63
|
Complex electrocardiographic findings in a neonate with long QT syndrome.
|
Ital Heart J
|
2002
|
0.75
|
|
64
|
Too much electricity through the power lines: a case of left bundle-branch focal tachycardia.
|
Acta Cardiol
|
2014
|
0.75
|
|
65
|
Asystole detected by implantable loop recorders: true or false?
|
Ann Noninvasive Electrocardiol
|
2014
|
0.75
|
|
66
|
Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
0.75
|
|
67
|
[Catheter ablation in atrial fibrillation: a valid therapeutic option also for older patients?].
|
G Ital Cardiol (Rome)
|
2013
|
0.75
|